U.S. markets close in 3 hours 37 minutes
  • S&P 500

    4,639.66
    +72.66 (+1.59%)
     
  • Dow 30

    34,886.58
    +402.86 (+1.17%)
     
  • Nasdaq

    15,736.81
    +199.12 (+1.28%)
     
  • Russell 2000

    2,230.23
    +31.32 (+1.42%)
     
  • Crude Oil

    67.54
    +1.36 (+2.06%)
     
  • Gold

    1,787.20
    +10.70 (+0.60%)
     
  • Silver

    22.52
    -0.29 (-1.27%)
     
  • EUR/USD

    1.1326
    -0.0013 (-0.11%)
     
  • 10-Yr Bond

    1.4600
    +0.0170 (+1.18%)
     
  • GBP/USD

    1.3317
    +0.0016 (+0.12%)
     
  • USD/JPY

    112.8810
    -0.2990 (-0.26%)
     
  • BTC-USD

    58,605.09
    +1,491.74 (+2.61%)
     
  • CMC Crypto 200

    1,493.13
    +24.05 (+1.64%)
     
  • FTSE 100

    7,168.68
    +109.23 (+1.55%)
     
  • Nikkei 225

    27,935.62
    +113.86 (+0.41%)
     

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of GERN, ALGN and CRON

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / March 20, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Geron Corporation (GERN)

Investors Affected : March 19, 2018 - September 26, 2018

A class action has commenced on behalf of certain shareholders in Geron Corporation. The filed complaint alleges that defendants misled investors regarding a drug called imetelstat, which was intended to treat certain cancers that occur in bone marrow. Specifically, defendants misled investors about the results of a clinical drug study of imetelstat called IMbark. That study was designed to ascertain whether imetelstat helped patients with a cancer called myelofibrosis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/geron-corporation-et-al-loss-submission-form/?id=5761&from=1

Align Technology, Inc. (ALGN)

Investors Affected : April 24, 2019 - July 24, 2019

A class action has commenced on behalf of certain shareholders in Align Technology, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) Align was then experiencing a significant decline in demand for its products in the important Chinese market; (b) Chinese consumer sentiment towards the Company was deteriorating; and (c) as a result of the foregoing, Defendants' positive statements about Align and its businesses were lacking in a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/align-technology-inc-loss-submission-form/?id=5761&from=1

Cronos Group Inc. (CRON)

Investors Affected : May 9, 2019 - March 2, 2020

A class action has commenced on behalf of certain shareholders in Cronos Group Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Cronos had engaged in significant transactions for which its revenue recognition was inappropriate; (ii) the foregoing would foreseeably necessitate reviews that would delay the Company's ability to timely file its periodic reports; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/cronos-group-inc-loss-submission-form/?id=5761&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm



View source version on accesswire.com:
https://www.accesswire.com/581817/The-Gross-Law-Firm-Announces-Class-Actions-on-Behalf-of-Shareholders-of-GERN-ALGN-and-CRON